Charles Schwab’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-220,853
Closed -$1.88M 3122
2013
Q3
$1.88M Sell
220,853
-97,556
-31% -$617K ﹤0.01% 1882
2013
Q2
$1.39M Buy
+318,409
New +$1.71M ﹤0.01% 1973

Charles Schwab's ASTX Position: Q4 2013 in Review

Charles Schwab sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 220,853 shares — an estimated $1.88M sold.

Charles Schwab first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $1.88M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Charles Schwab reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Charles Schwab sold 220,853 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $1.88M.
  • Charles Schwab first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Charles Schwab's ASTEX PHARMACEUTICALS, INC COM position peaked at $1.88M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Charles Schwab's 13F filing for Q4 2013, filed 14 Feb 2014.